44,936 Shares in Kenvue Inc. $KVUE Acquired by Meiji Yasuda Asset Management Co Ltd.

Meiji Yasuda Asset Management Co Ltd. purchased a new stake in Kenvue Inc. (NYSE:KVUE) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 44,936 shares of the company’s stock, valued at approximately $859,000.

Other hedge funds have also added to or reduced their stakes in the company. Callan Family Office LLC acquired a new stake in Kenvue during the second quarter worth approximately $835,000. Calamos Advisors LLC boosted its holdings in shares of Kenvue by 24.1% during the first quarter. Calamos Advisors LLC now owns 3,351,000 shares of the company’s stock worth $57,771,000 after acquiring an additional 651,000 shares during the period. State of Wyoming grew its position in shares of Kenvue by 233.5% in the fourth quarter. State of Wyoming now owns 97,992 shares of the company’s stock valued at $1,690,000 after purchasing an additional 68,609 shares during the last quarter. Nomura Asset Management Co. Ltd. grew its position in shares of Kenvue by 21.5% in the fourth quarter. Nomura Asset Management Co. Ltd. now owns 3,491,548 shares of the company’s stock valued at $60,229,000 after purchasing an additional 618,720 shares during the last quarter. Finally, Nuance Investments LLC bought a new position in shares of Kenvue during the second quarter worth approximately $27,681,000. Institutional investors and hedge funds own 97.64% of the company’s stock.

Analysts Set New Price Targets

Several analysts recently weighed in on the company. Zacks Research cut Kenvue from a “strong-buy” rating to a “hold” rating in a report on Tuesday, July 7th. UBS Group lowered their price objective on Kenvue from $20.00 to $19.00 and set a “neutral” rating on the stock in a research report on Tuesday, August 11th. Barclays lifted their target price on Kenvue from $18.00 to $19.00 and gave the stock an “equal weight” rating in a report on Tuesday, July 21st. Wall Street Zen cut shares of Kenvue from a “buy” rating to a “hold” rating in a research report on Saturday, August 8th. Finally, Weiss Ratings upgraded shares of Kenvue from a “hold (c-)” rating to a “hold (c)” rating in a research note on Monday, June 15th. Three investment analysts have rated the stock with a Buy rating and twelve have given a Hold rating to the company’s stock. According to MarketBeat, Kenvue presently has an average rating of “Hold” and a consensus target price of $19.27.

Kenvue Price Performance

Kenvue stock opened at $19.34 on Wednesday. The firm has a market cap of $37.16 billion, a PE ratio of 22.24, a price-to-earnings-growth ratio of 1.39 and a beta of 0.47. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.01 and a quick ratio of 0.71. The stock’s fifty day moving average price is $19.10 and its two-hundred day moving average price is $18.22. Kenvue Inc. has a one year low of $14.02 and a one year high of $21.40.

Kenvue (NYSE:KVUE) last released its earnings results on Thursday, August 6th. The company reported $0.31 earnings per share for the quarter, missing analysts’ consensus estimates of $0.32 by ($0.01). The company had revenue of $3.96 billion for the quarter, compared to the consensus estimate of $3.97 billion. Kenvue had a net margin of 10.76% and a return on equity of 21.22%. The business’s revenue was up 3.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.29 earnings per share. As a group, research analysts expect that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, August 26th. Investors of record on Wednesday, August 12th will be paid a $0.21 dividend. This represents a $0.84 dividend on an annualized basis and a yield of 4.3%. This is a boost from Kenvue’s previous quarterly dividend of $0.21. The ex-dividend date of this dividend is Wednesday, August 12th. Kenvue’s payout ratio is presently 96.55%.

Kenvue Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.